Literature DB >> 15148455

Continuous renal replacement technology: from adaptive technology and early dedicated machines towards flexible multipurpose machine platforms.

Zaccaria Ricci1, Monica Bonello, Gabriella Salvatori, Ranistha Ratanarat, Alessandra Brendolan, Maurizio Dan, Rinaldo Bellomo, Claudio Ronco.   

Abstract

Mesh：

Year:  2004        PMID： 15148455     DOI： 10.1159/000078431

Source DB:  PubMed          Journal:  Blood Purif        ISSN： 0253-5068            Impact factor:   2.614


× No keyword cloud information.
  7 in total

Review 1.  Renal replacement therapies: physiological review.

Authors:  Claudio Ronco; Zaccaria Ricci
Journal:  Intensive Care Med       Date:  2008-09-13       Impact factor: 17.440

2.  One-year safe use of the Prismaflex HF20(®) disposable set in infants in 220 renal replacement treatment sessions.

Authors:  Siegfried Rödl; Ingrid Marschitz; Christoph J Mache; Martin Koestenberger; Georg Madler; Thomas Rehak; Gerfried Zobel
Journal:  Intensive Care Med       Date:  2011-02-19       Impact factor: 17.440

3.  Pediatric continuous renal replacement: 20 years later.

Authors:  Claudio Ronco; Zaccaria Ricci
Journal:  Intensive Care Med       Date:  2015-04-17       Impact factor: 17.440

Review 4.  Isolated ultrafiltration in heart failure patients.

Authors:  Maria Rosa Costanzo; Claudio Ronco
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 5.  Renal Replacement Therapy.

Authors:  Zaccaria Ricci; Stefano Romagnoli; Claudio Ronco
Journal:  F1000Res       Date:  2016-01-25

Review 6.  The future of critical care: renal support in 2027.

Authors:  William R Clark; Mauro Neri; Francesco Garzotto; Zaccaria Ricci; Stuart L Goldstein; Xiaoqiang Ding; Jiarui Xu; Claudio Ronco
Journal:  Crit Care       Date:  2017-04-11       Impact factor: 9.097

Review 7.  Continuous Renal Replacement Therapy in the Critically Ill Patient: From Garage Technology to Artificial Intelligence.

Authors:  Sara Samoni; Faeq Husain-Syed; Gianluca Villa; Claudio Ronco
Journal:  J Clin Med       Date:  2021-12-29       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.